Semaxanib | Health Canada Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Semaxanib
Health Canada Patents

EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

Contact Supplier

SPI Pharma has been solving formulation challenges using superior functional materials.

Contact Supplier

Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

Contact Supplier

Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

Contact Supplier

FAMAR CDMO- From early development to commercial manufacturing.

Contact Supplier

Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

Contact Supplier

Semaxanib

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

3 NDC API

3 NDC API

FINISHED DOSAGE FORMULATIONS

21 FDF Dossiers, 1 FDA Orange Book, 13 Europe, 2 Canada, 4 Australia, 1 South Africa

21 FDF Dossiers
1 FDA Orange Book
13 Europe
2 Canada
4 Australia
1 South Africa

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc, 13 SPI Pharma, 1 Faran Shimi Pharmaceutical, 1 Gangwal Healthcare, 1 Nanjing Well Pharmaceutical, 3 Pfanstiehl, 2 Actylis, 2 BASF, 3 Gangwal Chemicals, 1 Ingredion Pharma Solutions, 2 Kerry, 2 Microlex e.U, 1 Pluviaendo, 3 Roquette, 2 Seppic, 1 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 1 Sigachi Industries

1 Rochem International Inc
13 SPI Pharma
1 Faran Shimi Pharmaceutical
1 Gangwal Healthcare
1 Nanjing Well Pharmaceutical
3 Pfanstiehl
2 Actylis
2 BASF
3 Gangwal Chemicals
1 Ingredion Pharma Solutions
2 Kerry
2 Microlex e.U
1 Pluviaendo
3 Roquette
2 Seppic
1 Shanghai Shenmei Pharmaceutical Technology Co., Ltd
1 Shijiazhuang Huaxu Pharmaceutical
1 Sigachi Industries

EXCIPIENTS BY APPLICATIONS

17 Fillers, Diluents & Binders, 12 Taste Masking, 11 Chewable & Orodispersible Aids, 10 Direct Compression, 9 Parenteral, 7 Disintegrants & Superdisintegrants, 5 Co-Processed Excipients, 5 Solubilizers, 4 Thickeners and Stabilizers, 3 Granulation, 2 Surfactant & Foaming Agents, 2 Coating Systems & Additives, 2 Topical, 1 Emulsifying Agents

17 Fillers, Diluents & Binders
12 Taste Masking
11 Chewable & Orodispersible Aids
10 Direct Compression
9 Parenteral
7 Disintegrants & Superdisintegrants
5 Co-Processed Excipients
5 Solubilizers
4 Thickeners and Stabilizers
3 Granulation
2 Surfactant & Foaming Agents
2 Coating Systems & Additives
2 Topical
1 Emulsifying Agents

DIGITAL CONTENT

3 NEWS #PharmaBuzz

3 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 9 Finished Drug Prices, 7 Annual Reports

1 US Medicaid Prescriptions
9 Finished Drug Prices
7 Annual Reports

MARKET PLACE

2 APIs, 3 FDF Dossiers

2 APIs
3 FDF Dossiers

PATENTS & EXCLUSIVITIES

2 Health Canada Patents

2 Health Canada Patents

Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Reset all filters

2 All

01 2Amgen Canada Inc.

filter Patent Reset all filters

2 All

01 22346996

filter Product Reset all filters

2 All

01 2ROMIPLOSTIM

filter Dosage Reset all filters

2 All

01 2POWDER FOR SOLUTION

filter Exp Date Reset all filters

2 All

01 22019-10-22

Product Main Page

01

Amgen Canada Inc.

Semaxanib

BioAsia

Not Confirmed

Amgen Canada Inc.

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2019-10-22

Date Granted : 2013-11-19

Brand Name : NPLATE

Patent Number : 2346996

Filing Date : 1999-10-22

Strength per Unit : 250 ?g / 0.5 mL

Dosage Form : POWDER FOR SOLUTION

Human Or VET : Human

Route of Administration : SUBCUTANEOUS

Patent Expiration Date : 2019-10-22

Date Granted : 2013-11-19

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

Amgen Canada Inc.

Semaxanib

BioAsia

Not Confirmed

Amgen Canada Inc.

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2019-10-22

Date Granted : 2013-11-19

Brand Name : NPLATE

Patent Number : 2346996

Filing Date : 1999-10-22

Strength per Unit : 500 ?g / 1 mL

Dosage Form : POWDER FOR SOLUTION

Human Or VET : Human

Route of Administration : SUBCUTANEOUS

Patent Expiration Date : 2019-10-22

Date Granted : 2013-11-19

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
ASK US!